Clinical Trials in Sanmenxia, China
Locations / Sanmenxia, China
Delta Trials hosts 52 clinical trials conducted in Sanmenxia, China, making it a notable site of clinical research activity. These trials covering 56 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Sanmenxia.
52
Total Trials
56
Conditions
1
Terminated since 2020
Browse by condition (56 total)
- Atopic dermatitis 5 trialsAll Atopic dermatitis trials
- Transient ischemic attack 3 trialsAll Transient ischemic attack trials
- All Respiratory syncytial virus infection trials
- Plaque psoriasis 2 trialsAll Plaque psoriasis trials
- All St segment elevation myocardial infarction trials
- Ischemic stroke, acute 2 trialsAll Ischemic stroke, acute trials
- Ischemic stroke 2 trialsAll Ischemic stroke trials
- Adverse drug reactions 2 trialsAll Adverse drug reactions trials
- Mental health issue 1 trialAll Mental health issue trials
- All Moderate to severe plaque psoriasis trials
- All Nash - nonalcoholic steatohepatitis trials
- Tia 1 trialAll Tia trials
- Chronic hepatitis b 1 trialAll Chronic hepatitis b trials
- All Primary percutaneous coronary intervention trials
- Diabetic kidney disease 1 trialAll Diabetic kidney disease trials
- Mild 1 trialAll Mild trials
- All Advanced gastric or gastroesophageal junction adenocarcinoma trials
- Chronic systolic heart failure 1 trialAll Chronic systolic heart failure trials
- Plaque psoriasis patients 1 trialAll Plaque psoriasis patients trials
- All Moderate to severe chronic obstructive pulmonary disease (copd) trials